Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (101-110 of 191) with videos related to

Pageof 20
Sort By:
Obstetrics and Gynecology|December 1, 1994
Evaluation of prognostic factors and staging in gestational trophoblastic tumorJ T Soper, A C Evans, M R Conaway, et al.
American Journal of Obstetrics and Gynecology|September 1, 1996
Role of BRCA1 mutation screening in the management of familial ovarian cancerA Berchuck, F Cirisano, J M Lancaster, et al.
Cancer Research|December 1, 1995
Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activityJ I Risinger, A Umar, J C Boyer, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell linesG C Rodríguez, M P Boente, A Berchuck, et al.
Cancer Research|October 15, 1996
Cell cycle control of BRCA2J P Vaughn, F D Cirisano, G Huper, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Molecular approaches to prevention and detection of epithelial ovarian cancerR C Bast, C M Boyer, F J Xu, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
American Journal of Obstetrics and Gynecology|March 1, 1995
Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancerJ M Schildkraut, N K Collins, G A Dent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristicsJ I Risinger, K Hayes, G L Maxwell, et al.
Pageof 20

Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
Obstetrics and Gynecology|December 1, 1994
Evaluation of prognostic factors and staging in gestational trophoblastic tumorJ T Soper, A C Evans, M R Conaway, et al.
American Journal of Obstetrics and Gynecology|September 1, 1996
Role of BRCA1 mutation screening in the management of familial ovarian cancerA Berchuck, F Cirisano, J M Lancaster, et al.
Cancer Research|December 1, 1995
Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activityJ I Risinger, A Umar, J C Boyer, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell linesG C Rodríguez, M P Boente, A Berchuck, et al.
Cancer Research|October 15, 1996
Cell cycle control of BRCA2J P Vaughn, F D Cirisano, G Huper, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Molecular approaches to prevention and detection of epithelial ovarian cancerR C Bast, C M Boyer, F J Xu, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
American Journal of Obstetrics and Gynecology|March 1, 1995
Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancerJ M Schildkraut, N K Collins, G A Dent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristicsJ I Risinger, K Hayes, G L Maxwell, et al.
Pageof 20